Gyre Therapeutics, Inc. GYRE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$9.86M— | —— | $5.94M+277% | $1.58M-57.8% | $3.73M+556% | ||
| $672K+2.4% | $656K+1.1% | $649K+1.2% | $641K+19.8% | $535K+16.1% | ||
| $2.58M-43.8% | $4.6M+301% | $1.15M+26.6% | $906K+78.7% | $507K-10.6% | ||
| $3.18M— | —— | $4.68M+124% | $2.09M+1,719% | -$129K+95.3% | ||
| $178K+23.6% | $144K-78.4% | $668K+161% | $256K+110% | $122K— | ||
| -$3.06M— | —— | -$1.25M+59.0% | -$3.04M-255% | $1.97M+198% | ||
| $21K-93.4% | $318K-12.9% | $365K-98.4% | $22.35M+1,563% | $1.34M+39.4% | ||
| $431K— | —— | $3.91M-81.8% | $21.45M+564% | $3.23M+180% | ||
| $3M+152% | -$5.77M-244% | $4.01M+119% | $1.83M+830% | -$251K+90.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Gyre Therapeutics, Inc. generate?
- Gyre Therapeutics, Inc. (GYRE) generated $9.8M in operating cash flow over the trailing twelve months.
- What is Gyre Therapeutics, Inc.'s free cash flow?
- After $1.2M of capital expenditures, Gyre Therapeutics, Inc.'s free cash flow was $3.1M over the trailing twelve months, up 142.4% year over year.
- Where does Gyre Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Gyre Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
